Post-Conference Session: Stability studies to support shipping/distribution of Pharmaceuticals and Biopharmaceuticals

1 December 2017, Vienna, Austria

Course No. 16229

header-image

Speakers

Dr Raphael Bar, BR Consulting, Israel

Objectives

This session will give a comprehensive overview of tools that a Qualified Person (QP), Quality Assurance personnel or a Product Manager/ Manufacturer should have in order to evaluate the impact of excursions from the storage label instructions on the disposition of distributed shipments of pharmaceutical/biopharmaceutical products.

Background

The formal stability studies of pharmaceuticals and biopharmaceuticals are a well established discipline and they are regularly conducted at precisely monitored conditions of temperature (within 2°C) and of humidity (within 5% RH) under cGMP. However, the inevitable processes of shipping and distributing medicines from the manufacturer to wholesaler to warehouses to the end user via air, ship or car exposes often the shipments to temperatures and humidity different from the label storage conditions. For instance, how would you handle a shipment that was exposed to a varying temperature up to 61°C in the airport for an accumulated duration of several days? How would you evaluate the quality of a refrigerated injectable that was exposed to near zero or freezing temperatures for a few hours? Would you release or reject such a shipment which may cost hundreds of thousands of dollars?

Shipping/Distribution of a medicine is considered a “mobile storage”. However, a temperature excursion outside the label instructions may also be considered a ‘trauma” inflicted on the medicine and this may impact the quality of the newly arrived shipments. But the big question remains: how would that ‘trauma” affect the quality at the end of the declared shelf life of any pharmaceutical and of a biopharmaceutical in particular? Will the long-term impact lead to a “hidden OOS”?

This course will address these aspects. Finally, a workshop will demonstrate how the evaluation of an example of a temperature excursion may be approached

Workshop

Evaluation of a Temperature Excursion in shipped refrigerated drug product.

Programme

Overview of stability programs and Stress Testing– regulatory view (GMP and GDP)

  • Long-term and accelerated storage conditions of new drug substances and products (EU, USA)
  • Stability storage programs for generic drugs (EU, USA)
  • Stress testing vs Forced Degradations
  • Stressing factors
  • GDP Guides (EU, WHO, USP Chapter <1079> )
  • “Time-out-of-Storage” and “stability budget“ concept
Overview of qualification of shipment of pharmaceuticals and Temperature Monitoring
  • The four Qs: DQ, IQ, OQ and PQ
  • Temperature monitoring in a shipment
World climatic zones and Mean Kinetic Temperature (MKT)
  • Mean Kinetic Temperature (MKT) and relative humidity
  • Interpretation of MKT
  • MKT from temperature loggers
  • Global climatic zones by ICH and WHO
Storage label statements (EU and USA)
  • Linking storage instructions to formal stability studies
  • Labeling statements for various pharmaceuticals (EMA guideline)
  • USP controlled temperatures
Stability studies to support shipping/distribution of pharmaceuticals and
biopharmaceuticals

  • Studies at elevated extreme temperatures
  • Studies at low extreme conditions
  • When, how and what?
  • Thermal Cyclic studies
  • What attributes to test
Investigation of excursions from storage label conditions
  • Handling an excursion
  • What stability data are required to investigate temperature excursions
  • Responsibilities of manufacturer, distributor and QP
Evaluation of Temperature Excursions
  • Estimation of degradation rates at the excursion temperature
  • Estimation of degradation at the expected long-term shelf-life
  • Estimation of a maximal “Time-out-of-Storage” of a drug

This post-Conference Session ideally complements the ECA education courses
“Setting Specifications” (28-29 November 2017 in Vienna, Austria)
and
“Stability Testing of Drug Substances and Drug Products”
(29-30 November 2017 in Vienna, Austria).

stop

This course is part of the GMP Certification Programme "ECA Certified Quality Control Manager" Learn more

This training/webinar cannot be booked. Send us your inquiry by using the following contact form.

To find alternative dates for this training/webinar or similar events please see the complete list of all events.

For many training courses and webinars, there are also recordings you can order and watch any time. Just take a look at the complete list of all recordings.

* also payable by credit card
American Express Visa Mastercard

icon
Further dates on-site
Further dates on-site
Not available
icon
Further dates online
Further dates online
Not available
icon
Recording
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023